GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helixmith Co Ltd (XKRX:084990) » Definitions » Interest Income

Helixmith Co (XKRX:084990) Interest Income : ₩3,512 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Helixmith Co Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Helixmith Co's interest income for the three months ended in Sep. 2024 was ₩905 Mil. Its interest income for the trailing twelve months (TTM) ended in Sep. 2024 was ₩3,512 Mil.


Helixmith Co Interest Income Historical Data

The historical data trend for Helixmith Co's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helixmith Co Interest Income Chart

Helixmith Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,801.79 9,452.31 2,969.07 2,295.06 3,172.68

Helixmith Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 733.56 816.76 895.49 894.65 905.03

Helixmith Co Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,512 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Helixmith Co Business Description

Traded in Other Exchanges
N/A
Address
1 Gwanak-ro, Gwanak-gu, 5th Floor, Building Number 203, Seoul National University, Seoul, KOR, 08826
Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.

Helixmith Co Headlines

No Headlines